Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...

Accurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

March is a significant month for women's health, observing International Women's Day and National Women's HIV/AIDS Awareness ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...